Incidence of Ketoacidosis in the Danish Type 2 Diabetes Population Before and After Introduction of Sodium–Glucose Cotransporter 2 Inhibitors—A Nationwide, Retrospective Cohort Study, 1995–2014
Open Access
- 10 March 2017
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 40 (5), e57-e58
- https://doi.org/10.2337/dc16-2793
Abstract
The U.S. Food and Drug Administration warns that sodium–glucose cotransporter 2 (SGLT2) inhibitors may lead to diabetic ketoacidosis (DKA). To establish a baselKeywords
This publication has 3 references indexed in Scilit:
- Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical ProgramDiabetes Care, 2015
- Validation of the Danish National Diabetes RegisterClinical Epidemiology, 2014
- The National Diabetes RegisterScandinavian Journal of Public Health, 2011